Key facts
- Notable investors include Artesian.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Trial Data
- ·The full record, as it builds
Funding rounds
No funding rounds for Trial Data are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Trial Data
Developer of a remote intelligent clinical research service platform designed to streamline patient-centred clinical trials and data management. The company offers a comprehensive suite of integrated platforms and systems, including remote monitoring, subject recruitment, electronic consent, supply chain management, and data analysis tools, enabling clinical research institutions to enhance trial efficiency and data accuracy.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2018
- Website
- trialdata.cn/
- Ownership
- Privately Held (backing)
Trial Data doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Trial Data shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Trial Data in its N-PORT filings yet. We sweep new filings monthly.